Ireland· IE-PA-EU/1/25/1960/001
Zemcelpro ≥ 0.23×106 viable CD34+ cells/mL/≥ 0.53×106 viable CD3+ cells/mL dispersion for infusion
A stammzellen aus nabelschnurblut product containing haematopoietic stem cells and blood progenitor umbilical cord-derived expanded with (1r, 4r)-n1-(2-benzyl-7-(2-methyl-2h-tetrazol-5-yl)-9h-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate, registered in Ireland by Cordex Biologics International Limited. The same ATC class is registered in 8 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Stammzellen aus nabelschnurblut is registered in 8 of 19 countries.
Countries holding a registration under ATC B05AX04 (stammzellen aus nabelschnurblut), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 5 of them publish a price we can compare per daily dose
Stammzellen aus nabelschnurblut · ATC B05AX04
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Haematopoietic stem cells and blood progenitor umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate
- Manufacturer
- Cordex Biologics International Limited
- Country
- Ireland (IE)
- ATC code
- B05AX04
- ATC class
- Stammzellen aus Nabelschnurblut
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/25/1960/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B05AX04
Stammzellen aus nabelschnurblut, as other registers publish it.
- PolandZemcelproCordex Biologics International Limited
- FinlandZemcelproCordex Biologics International Limited
- DenmarkZemcelproCordex Biologics International Limited
- IcelandZemcelproCordex Biologics International Limited
- CzechiaZEMCELPROCordex Biologics International Limited, Dublin
- NetherlandsZemcelpro ¿ 0,23 × 106 levensvatbare CD34+-cellen/ml / ¿ 0,53 × 106 levensvatbare CD3+-cellen/ml dispersie voor infusieCordex Biologics International Limited
- BelgiumZemcelpro 0.23 10*6 cells/ml - 0.53 10*6 cells/mlCordex Biologics International
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2960a698-fc21-44bf-91ae-62af181efa88 GET /v1/drugs/2960a698-fc21-44bf-91ae-62af181efa88?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Dispersion for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"B05AX04"
],
"strength": null,
"pa_number": "EU/1/25/1960/001",
"substances": [
"Haematopoietic stem cells and blood progenitor umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "25/08/2025",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about stammzellen aus nabelschnurblut.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.